Preclinical Activity of New [1,2]Oxazolo[5,4-<i>e</i>]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma
Virginia Spanò(University of Palermo), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), Anna Carbone(University of Palermo), Patrizia Diana(University of Palermo), Vincenzo Cilibrasi(University of Palermo), Alessandra Montalbano(University of Palermo), Barbara Parrino(University of Palermo), Alessia Lopergolo(Fondazione IRCCS Istituto Nazionale dei Tumori), Valentina Zuco(Fondazione IRCCS Istituto Nazionale dei Tumori), Girolamo Cirrincione(University of Palermo), Paola Barraja(University of Palermo), Denis Cominetti(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 49
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348